Michael Patrick Akers,Chi A. Nguyen,Chad D. Paavola,Virender Kumar Sarin,Nanette Elizabeth Schulte,Ranajoy Majumdar
申请号：
US15978329
公开号：
US20190231851A1
申请日:
2018.05.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.
